Crinetics Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 3.24 M

Crinetics Pharmaceuticals, Inc. Depreciation And Amortization is USD 3.24 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 151.05% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Crinetics Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.29 M, a 25.63% change year over year.
  • Crinetics Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.03 M, a 9.38% change year over year.
  • Crinetics Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 938.00 K, a 0.11% change year over year.
  • Crinetics Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 937.00 K, a 7.83% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased